Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Poglitsch

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 15, 2010
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunityMichael Haidinger, Manfred Hecking, Thomas Weichhart, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 8, 2016
Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exerciseDaisy Motta-Santos, Robson Augusto Souza Dos Santos, Marilene Oliveira, et al.
Journal of Personalized Medicine|June 2, 2021
Renin Feedback Is an Independent Predictor of Outcome in HFpEFChristina Binder, Marko Poglitsch, Franz Duca, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2021
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for HypertensionRhéure Alves-Lopes, Augusto C Montezano, Karla B Neves, et al.
BMC Medical Research Methodology|May 27, 2023
Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studiesMaeregu Woldeyes Arisido, Luisa Foco, Robin Shoemaker, et al.
Journal of the American College of Cardiology|April 9, 2021
Myocardial Angiotensin Metabolism in End-Stage Heart FailureNoemi Pavo, Suriya Prausmüller, Georg Spinka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 25, 2016
Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patientsJohannes J Kovarik, Chantal Kopecky, Marlies Antlanger, et al.
Hypertension (Dallas, Tex. : 1979)|April 30, 2019
Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver AngiotensinogenEstrellita Uijl, Katrina M Mirabito Colafella, Yuan Sun, et al.
Clinical Science (London, England : 1979)|January 6, 2021
No evidence for brain renin-angiotensin system activation during DOCA-salt hypertensionEstrellita Uijl, Liwei Ren, Katrina M Mirabito Colafella, et al.
Journal of Hypertension|December 13, 2023
Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effectsEdwyn O Cruz-López, Dien Ye, Daniel G Stolk, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Transplant International : Official Journal of the European Society for Organ Transplantation|January 15, 2010
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunityMichael Haidinger, Manfred Hecking, Thomas Weichhart, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 8, 2016
Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exerciseDaisy Motta-Santos, Robson Augusto Souza Dos Santos, Marilene Oliveira, et al.
Journal of Personalized Medicine|June 2, 2021
Renin Feedback Is an Independent Predictor of Outcome in HFpEFChristina Binder, Marko Poglitsch, Franz Duca, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2021
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for HypertensionRhéure Alves-Lopes, Augusto C Montezano, Karla B Neves, et al.
BMC Medical Research Methodology|May 27, 2023
Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studiesMaeregu Woldeyes Arisido, Luisa Foco, Robin Shoemaker, et al.
Journal of the American College of Cardiology|April 9, 2021
Myocardial Angiotensin Metabolism in End-Stage Heart FailureNoemi Pavo, Suriya Prausmüller, Georg Spinka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 25, 2016
Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patientsJohannes J Kovarik, Chantal Kopecky, Marlies Antlanger, et al.
Hypertension (Dallas, Tex. : 1979)|April 30, 2019
Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver AngiotensinogenEstrellita Uijl, Katrina M Mirabito Colafella, Yuan Sun, et al.
Clinical Science (London, England : 1979)|January 6, 2021
No evidence for brain renin-angiotensin system activation during DOCA-salt hypertensionEstrellita Uijl, Liwei Ren, Katrina M Mirabito Colafella, et al.
Journal of Hypertension|December 13, 2023
Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effectsEdwyn O Cruz-López, Dien Ye, Daniel G Stolk, et al.
Pageof 9